{
  "schema_version": "0.1.0",
  "case_id": "HR-ML046",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML046",
    "display_name": "Flannery O'Connor",
    "aliases": [
      "Mary Flannery O'Connor"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1925-03-25",
          "display": "March 25, 1925",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1925",
              "display": "1925",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited biographies."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1964-08-03",
          "display": "August 3, 1964",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1964",
              "display": "1964",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited biographies."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML046-SYN",
      "ssn": "000-46-1853",
      "date_of_birth": "2001-03-25",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Augusta Pemberton-Diallo, MD",
      "fictional_consultant": {
        "name": "Rafael Okonjo-Strand, MD",
        "specialty": "Rheumatology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1925-03-25",
        "display": "March 25, 1925",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Savannah, Georgia.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1937",
        "display": "1937",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Her father's lupus diagnosed after an illness first thought to be rheumatoid arthritis.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1941",
        "display": "1941",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Her father died of systemic lupus erythematosus.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1947",
        "display": "1947",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Completed the Iowa Writers' Workshop.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1949-12",
        "display": "December 1949",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Month-long hospital stay in Georgia with an operation for a floating kidney.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1950-12",
        "display": "1950, by December",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Joint pain in Connecticut, suspected to be rheumatoid arthritis; in December, admitted to hospital in Georgia and diagnosed with systemic lupus erythematosus in Atlanta.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006",
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1951",
        "display": "1951",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Learned her diagnosis from a friend; treated with daily ACTH injections; moved to Andalusia.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008",
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1952",
        "display": "1952",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wise Blood published.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1954",
        "display": "Spring 1954",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Limp and hip pain from bone damage attributed to steroids; crutches for most of her remaining years.",
      "claim_ids": [
        "CLM-0010",
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1961",
        "display": "First half of 1961",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Steroids tapered; chloroquine added.",
      "claim_ids": [
        "CLM-0013"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1964",
        "display": "Early 1964",
        "precision": "approximate",
        "calendar": "gregorian"
      },
      "summary": "Surgery for a bleeding fibroid tumor reactivated her lupus; her kidneys were affected.",
      "claim_ids": [
        "CLM-0014"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1964-08-03",
        "display": "August 3, 1964",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Milledgeville, Georgia.",
      "claim_ids": [
        "CLM-0015"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Mary Flannery O'Connor was born in Savannah, Georgia, on March 25, 1925, the only child of Edward Francis O'Connor and Regina Cline O'Connor. She later dropped her first name for her writing.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Timeline, 1925"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Her father was diagnosed with lupus in 1937; his illness began with a whitish patch of skin on his forehead and arthritis, and was first diagnosed as rheumatoid arthritis. He died of systemic lupus erythematosus in 1941, a month after his 45th birthday, when she was 15.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented family history of systemic lupus erythematosus in a first-degree relative.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Timeline, 1941"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "O'Connor graduated from Georgia State College for Women in 1945 and then studied at the Writers' Workshop of the State University of Iowa, where she earned a Master of Fine Arts; she was writing her first novel by the late 1940s.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Timeline, 1942-47"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In December 1949, at 24, she fell seriously ill on a holiday visit to Georgia and spent about a month in hospital, where she had an operation for a floating kidney.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "A physician friend later speculated that this was the first sign of lupus; a review in a medical society journal notes that lupus nephritis is usually painless, so whether it was is unclear.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "A 1949 operation to correct a floating kidney"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "In 1950, while living in Connecticut and writing Wise Blood, O'Connor developed joint pain; rheumatoid arthritis was suspected, a diagnosis that later proved wrong.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented presentation that the synthetic episode echoes; the month of onset is not given.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In December 1950 she traveled home to Georgia by train and arrived looking very ill. She was admitted to hospital in Milledgeville, kidney disease was suspected, and on the advice of an Atlanta kidney specialist who suspected lupus she was moved to Emory Hospital in Atlanta, where a positive LE cell test confirmed systemic lupus erythematosus.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Sources date the diagnosis to late 1950 or January 1951; it was made in Atlanta.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Doctors in Atlanta diagnosed her condition as lupus"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Timeline, 1950"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Fearing the shock of her having the disease that had killed her father, her mother chose not to tell her the diagnosis; O'Connor learned that she had lupus from a friend in mid-1951.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented nondisclosure within the family; the synthetic episode tells her the diagnosis directly. No decision in the modern episode is attributed to any relative.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Citing her biographer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "She was discharged on daily injections of ACTH, which she learned to give herself, and was later treated with cortisone and prednisone. In early 1953 she wrote that she was nearly bald on top and had a \"watermelon face\".",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Hair loss and a round face are taken by the medical authors as signs of steroid treatment (iatrogenic Cushing syndrome).",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Massive injections of ACTH"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "From 1951 until 1964 O'Connor lived with her mother at Andalusia, the family farm outside Milledgeville, Georgia, where she wrote and kept peafowl and other birds.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "By the spring of 1954 she had a limp and progressive hip pain, and she used crutches for most of her remaining years. She later wrote that her doctors had found that her \"bone disintegration is being caused by the steroid drugs\" she had taken for years.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her own report of her physicians' finding, as quoted in a medical society journal.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Aluminum crutches"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "Physician authors attribute her hip disease to avascular necrosis of the femoral head from steroid treatment, and suggest that her jaw may have been affected in the same way.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Retrospective medical interpretation from her letters and photographs; no imaging from her lifetime was reviewed.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "Physician authors suggest from her letters and photographs that she may have had a malar facial rash early in her illness and the hand deformities of Jaccoud arthropathy.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation; not used as a historical finding.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0013",
      "statement": "Her steroid treatment was tapered in the first half of 1961, when she was also taking chloroquine.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Later than the synthetic episode and not used in it.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "In early 1964 she was anemic from a bleeding fibroid tumor and had abdominal surgery to remove it; the tumor was benign, but the operation reactivated her lupus, which had been in remission, and her kidneys were affected.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "One source describes the operation as a hysterectomy. Later than the synthetic episode and not used in it.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Timeline, 1964"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0016",
      "statement": "Her novel Wise Blood was published in 1952 and A Good Man Is Hard to Find and Other Stories in 1955; The Complete Stories won the National Book Award after her death.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0015",
      "statement": "O'Connor died of kidney failure from lupus in the Baldwin County Hospital in Milledgeville on August 3, 1964, at 39.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Record the death as a fact without detail.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Peacocks and the Red Wolf. The Pharos of Alpha Omega Alpha, Spring 2019:27-32",
      "publisher": "Alpha Omega Alpha Honor Medical Society",
      "url": "https://www.alphaomegaalpha.org/wp-content/uploads/2021/03/2019-2-Silver.pdf",
      "source_type": "scholarly",
      "published": "2019",
      "accessed": "2026-11-05",
      "rights_note": "Medical society journal article by two rheumatologists, drawing on her letters (The Habit of Being) and the standard biography; facts and short quotations of her letters used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Flannery O'Connor: biographical timeline (American Masters)",
      "publisher": "PBS (WNET)",
      "url": "https://www.pbs.org/wnet/americanmasters/flannery-oconnor-biographical-timeline/17555/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Public broadcaster timeline; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Flannery O'Connor (1925-1964). New Georgia Encyclopedia",
      "publisher": "Georgia Humanities and the University of Georgia Press",
      "url": "https://www.georgiaencyclopedia.org/articles/arts-culture/flannery-oconnor-1925-1964/",
      "source_type": "biography",
      "published": "2023-08-03",
      "accessed": "2026-11-05",
      "rights_note": "State encyclopedia entry by a Georgia College scholar; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "O'Connor, Flannery. Scribner Encyclopedia of American Lives, Thematic Series: The 1960s",
      "publisher": "Encyclopedia.com (Scribner)",
      "url": "https://www.encyclopedia.com/humanities/encyclopedias-almanacs-transcripts-and-maps/oconnor-flannery",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Reference biography; facts and short phrases used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Dances with wolves. Hektoen International, Spring 2016",
      "publisher": "Hektoen Institute of Medicine",
      "url": "https://hekint.org/2017/01/29/dances-with-wolves/",
      "source_type": "other",
      "published": "2016",
      "accessed": "2026-11-05",
      "rights_note": "Medical humanities essay quoting her letters; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Lupus in the mid-20th century: the life and death of Flannery O'Connor. J Clin Rheumatol 2011;17(5):266-268. PMID 21778907",
      "publisher": "Journal of Clinical Rheumatology (PubMed record)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/21778907/",
      "source_type": "scholarly",
      "published": "2011-08",
      "accessed": "2026-11-05",
      "rights_note": "Bibliographic record only; no abstract; cited as context and as a source used by source 1."
    },
    {
      "source_id": "SRC-0007",
      "title": "Flannery O'Connor's lupus. A commentary on her collected letters, The Habit of Being. JAMA 1980;244(13):1441-1442. PMID 6999184",
      "publisher": "JAMA (PubMed record)",
      "url": "https://pubmed.ncbi.nlm.nih.gov/6999184/",
      "source_type": "scholarly",
      "published": "1980-09-26",
      "accessed": "2026-11-05",
      "rights_note": "Bibliographic record only; no abstract; cited as context."
    },
    {
      "source_id": "SRC-0008",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-05",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-04-13",
    "index_age": 25,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize systemic lupus erythematosus in a woman of 25 with inflammatory arthritis, fever, a malar rash, cytopenias, and protein and blood in the urine, rather than calling it rheumatoid arthritis; classify it with the 2019 EULAR/ACR criteria (ANA, anti-dsDNA, anti-Sm, complements, antiphospholipid antibodies) and tell her the diagnosis directly. Measure the urine protein-to-creatinine ratio, biopsy the kidney, and treat class III lupus nephritis as the 2024 ACR and 2023 EULAR guidance advise: hydroxychloroquine for every patient with baseline eye screening, pulse then tapering glucocorticoids kept to 5 mg a day or less, mycophenolate with belimumab, and an angiotensin receptor blocker. Protect bone and watch for avascular necrosis, give vaccinations before immunosuppression, protect her from the sun, manage cardiovascular risk, plan contraception and any future pregnancy with her antiphospholipid status in mind, and protect her writing life. The teaching note contrasts this with the high-dose steroid treatment, the steroid bone damage, and the concealment of her diagnosis that she lived through.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-04-13",
        "purpose": "Primary care visit for joint pain and swelling, fevers, fatigue, a facial rash, and protein in the urine in a writer of 25"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-04-22",
        "purpose": "Diagnosis of systemic lupus erythematosus with the rheumatology consultation the same day; vaccinations before immunosuppression"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-29",
        "purpose": "Kidney biopsy result: class III lupus nephritis; start of pulse methylprednisolone, prednisone, mycophenolate, and belimumab"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-06-15",
        "purpose": "Same-day sick visit for bladder symptoms on immunosuppression"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-07-27",
        "purpose": "Three-month response assessment for lupus nephritis and glucocorticoid taper"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-05",
        "purpose": "Adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-26",
        "purpose": "Six-month response assessment: complete renal response; prednisone 5 mg; pregnancy planning"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be established",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M25.50",
            "display": "Pain in unspecified joint",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic presenting concern at the index visit, superseded by the diagnosis of systemic lupus erythematosus at the second visit; joint pain in 1950 with suspected rheumatoid arthritis is documented (D).",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-04-22"
      },
      {
        "id": "PRB-002",
        "display": "Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be established",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R80.9",
            "display": "Proteinuria, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting finding at the index visit, superseded by the kidney biopsy diagnosis at the third visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-04-29"
      },
      {
        "id": "PRB-003",
        "display": "Systemic lupus erythematosus, classified by the EULAR/ACR criteria (ANA 1:640 homogeneous; score 32 before the biopsy): inflammatory arthritis, acute cutaneous lupus (malar rash), fever, leukopenia with lymphopenia, mild thrombocytopenia, low C3 and C4, anti-dsDNA and anti-Sm positive; antiphospholipid antibodies and lupus anticoagulant negative",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M32.19",
            "display": "Other organ or system involvement in systemic lupus erythematosus",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern diagnosis and results; her systemic lupus erythematosus, diagnosed in Atlanta in late 1950 or early 1951, is documented (D), but no finding from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-04-22"
      },
      {
        "id": "PRB-004",
        "display": "Lupus nephritis, ISN/RPS class III (A), focal proliferative, on kidney biopsy: endocapillary proliferation in 9 of 30 glomeruli, activity index 6 of 24, chronicity index 1 of 12, full-house immunofluorescence; no thrombotic microangiopathy; urine protein-to-creatinine ratio 1.8 g/g; normal kidney function",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M32.14",
            "display": "Glomerular disease in systemic lupus erythematosus",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic biopsy result and class; kidney involvement is documented at the end of her life, but no kidney finding from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-29"
      },
      {
        "id": "PRB-005",
        "display": "Long-term glucocorticoid treatment for lupus nephritis, tapering to 5 mg a day or less",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.52",
            "display": "Long term (current) use of systemic steroids",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic treatment status; the documented steroid harm in her life is the reason the episode keeps glucocorticoids low.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-29"
      },
      {
        "id": "PRB-006",
        "display": "Long-term mycophenolate mofetil, with belimumab, for lupus nephritis; bone and infection protection in place",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z79.624",
            "display": "Long term (current) use of inhibitors of nucleotide synthesis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-29"
      },
      {
        "id": "PRB-007",
        "display": "Levonorgestrel intrauterine system for highly effective contraception during mycophenolate treatment",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z97.5",
            "display": "Presence of (intrauterine) contraceptive device",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic contraception, chosen by the patient.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-29"
      },
      {
        "id": "PRB-008",
        "display": "Acute cystitis on mycophenolate, belimumab, and prednisone 15 mg: two days of burning, frequency, and urgency without fever or flank pain; urine culture grew Escherichia coli sensitive to nitrofurantoin; resolved with seven days of nitrofurantoin",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N30.00",
            "display": "Acute cystitis without hematuria",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic common infection in an immunosuppressed young woman; coded without hematuria because the persistent hematuria is from her nephritis.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-06-15"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Two tablets up to every 8 hours as needed"
        },
        "start_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic analgesia; nonsteroidal anti-inflammatory drugs are avoided with protein in the urine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "as_needed": true
      },
      {
        "id": "MED-002",
        "display": "Hydroxychloroquine sulfate 300 mg oral tablet, one tablet by mouth once daily (5 mg/kg of actual body weight), long term",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2569283",
            "display": "hydroxychloroquine sulfate 300 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet once daily"
        },
        "start_date": "2026-04-22",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hydroxychloroquine, recommended for every patient with lupus at no more than 5 mg/kg a day.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Losartan potassium 25 mg oral tablet, one tablet by mouth once daily, for proteinuria and blood pressure",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979485",
            "display": "losartan potassium 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet once daily"
        },
        "start_date": "2026-04-22",
        "indication_problem_ids": [
          "PRB-002",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic angiotensin receptor blocker for proteinuria and a blood pressure above target.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Methylprednisolone 500 mg intravenous infusion once daily for three days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1743720",
            "display": "methylprednisolone 500 MG Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 500,
          "unit": "mg"
        },
        "route": "intravenous",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One infusion daily for three days"
        },
        "start_date": "2026-04-29",
        "end_date": "2026-05-01",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pulse glucocorticoids at the start of treatment for class III lupus nephritis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Prednisone 5 mg oral tablet: 30 mg (six tablets) once daily from the day after the last pulse, reduced by 5 mg every two weeks to 10 mg, then to 5 mg a day or less by six months",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312617",
            "display": "prednisone 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 30,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Once daily, tapering"
        },
        "start_date": "2026-04-29",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic oral glucocorticoid taper after pulses, kept to the lowest dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Mycophenolate mofetil 500 mg oral tablet, one tablet twice daily for one week, then two tablets (1000 mg) twice daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "200060",
            "display": "mycophenolate mofetil 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "Two tablets twice daily"
        },
        "start_date": "2026-04-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anchor immunosuppressant for class III lupus nephritis, 2 g a day; highly effective contraception in place first.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Belimumab 200 mg/mL subcutaneous autoinjector: 400 mg (two injections) once weekly for four doses, then 200 mg once weekly",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1939296",
            "display": "1 ML belimumab 200 MG/ML Auto-Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 200,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "Once weekly by self-injection"
        },
        "start_date": "2026-04-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic add-on biologic for active lupus nephritis, as the second immunosuppressive agent with mycophenolate.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199362",
            "display": "cholecalciferol 0.025 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet once daily"
        },
        "start_date": "2026-04-29",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin D with dietary calcium for bone protection on glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Nitrofurantoin (monohydrate/macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for seven days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1648755",
            "display": "nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One capsule twice daily for seven days"
        },
        "start_date": "2026-06-15",
        "end_date": "2026-06-21",
        "indication_problem_ids": [
          "PRB-008"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-line treatment for cystitis, extended to seven days because she is immunosuppressed; trimethoprim-sulfamethoxazole avoided in lupus.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 11.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 3.3,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V1",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 0.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 138,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 3.3,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 19,
        "unit": "U/L",
        "reference_range": {
          "high": 33
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ESR-V1",
        "display": "Erythrocyte [Sedimentation Rate] in Blood by Westergren method",
        "label": "ESR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 52,
        "unit": "mm/h",
        "reference_range": {
          "high": 20
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4537-7",
            "display": "Erythrocyte [Sedimentation Rate] in Blood by Westergren method",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CRP-V1",
        "display": "C reactive protein [Mass/volume] in Serum or Plasma",
        "label": "CRP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "high": 0.5
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1988-5",
            "display": "C reactive protein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UPCR-V1",
        "display": "Protein/Creatinine [Mass Ratio] in Urine",
        "label": "Urine protein-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 1.6,
        "unit": "g/g",
        "reference_range": {
          "high": 0.2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2890-2",
            "display": "Protein/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-URBC-V1",
        "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
        "label": "Urine red cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 18,
        "unit": "/[HPF]",
        "reference_range": {
          "high": 2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13945-1",
            "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic same-day tests for inflammatory joint pain with fever, rash, and an abnormal urine dipstick.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-13",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mild-range depression screen in a tired, unwell young woman.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V1",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Joint pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-04-13",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic joint pain score.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANA-V2",
        "display": "Nuclear Ab [Titer] in Serum by Immunofluorescence",
        "label": "ANA titer (HEp-2 immunofluorescence)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 640,
        "unit": "{titer}",
        "reference_range": {
          "high": 40,
          "text": "Negative at 1:40 or less; the EULAR/ACR entry criterion is 1:80 or higher"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "5048-4",
            "display": "Nuclear Ab [Titer] in Serum by Immunofluorescence",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DSDNA-V2",
        "display": "DNA double strand Ab [Units/volume] in Serum",
        "label": "Anti-dsDNA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 186,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 29
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "5130-0",
            "display": "DNA double strand Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-SM-V2",
        "display": "Smith extractable nuclear Ab [Units/volume] in Serum",
        "label": "Anti-Sm",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 42,
        "unit": "U/mL",
        "reference_range": {
          "high": 19
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "11090-8",
            "display": "Smith extractable nuclear Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C3-V2",
        "display": "Complement C3 [Mass/volume] in Serum or Plasma",
        "label": "Complement C3",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 62,
        "unit": "mg/dL",
        "reference_range": {
          "low": 90,
          "high": 180
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4485-9",
            "display": "Complement C3 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C4-V2",
        "display": "Complement C4 [Mass/volume] in Serum or Plasma",
        "label": "Complement C4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4498-2",
            "display": "Complement C4 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACLG-V2",
        "display": "Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay",
        "label": "Anticardiolipin IgG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 6,
        "unit": "U/mL",
        "reference_range": {
          "high": 20
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3181-5",
            "display": "Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ACLM-V2",
        "display": "Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay",
        "label": "Anticardiolipin IgM",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 4,
        "unit": "U/mL",
        "reference_range": {
          "high": 20
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3182-3",
            "display": "Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-B2GG-V2",
        "display": "Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum",
        "label": "Anti-beta-2 glycoprotein I IgG",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 3,
        "unit": "U/mL",
        "reference_range": {
          "high": 20
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "16135-6",
            "display": "Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-B2GM-V2",
        "display": "Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum",
        "label": "Anti-beta-2 glycoprotein I IgM",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 2,
        "unit": "U/mL",
        "reference_range": {
          "high": 20
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "16136-4",
            "display": "Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DRVVT-V2",
        "display": "dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)",
        "label": "Lupus anticoagulant (dRVVT screen-to-confirm ratio)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 1.04,
        "unit": "{ratio}",
        "reference_range": {
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "50410-0",
            "display": "dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UPCR-V2",
        "display": "Protein/Creatinine [Mass Ratio] in Urine",
        "label": "Urine protein-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 1.8,
        "unit": "g/g",
        "reference_range": {
          "high": 0.2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2890-2",
            "display": "Protein/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-URBC-V2",
        "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
        "label": "Urine red cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 22,
        "unit": "/[HPF]",
        "reference_range": {
          "high": 2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13945-1",
            "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic serology and urine studies drawn at the rheumatology consultation; results available the same afternoon.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 11.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 3.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V3",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 0.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 151,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "high": 33
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V3",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-29",
        "value": 26,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count, liver test, and vitamin D before mycophenolate and glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DXASPZ-V3",
        "display": "DXA Lumbar spine [Z-score] Bone density",
        "label": "Lumbar spine Z-score (DXA)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-04-29",
        "value": -0.4,
        "unit": "{Z-score}",
        "reference_range": {
          "low": -2.0,
          "text": "Z-score above -2.0 is within the expected range for age"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "85394-5",
            "display": "DXA Lumbar spine [Z-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline bone density at the start of high-dose glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DXAFEMZ-V3",
        "display": "DXA Femur [Z-score] Bone density",
        "label": "Femoral neck Z-score (DXA)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-04-29",
        "value": -0.2,
        "unit": "{Z-score}",
        "reference_range": {
          "low": -2.0,
          "text": "Z-score above -2.0 is within the expected range for age"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "80934-3",
            "display": "DXA Femur [Z-score] Bone density",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline bone density at the start of high-dose glucocorticoids.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 12.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 5.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V4",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 1.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 212,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V4",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 3.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "high": 33
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UPCR-V4",
        "display": "Protein/Creatinine [Mass Ratio] in Urine",
        "label": "Urine protein-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 0.9,
        "unit": "g/g",
        "reference_range": {
          "high": 0.2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2890-2",
            "display": "Protein/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-URBC-V4",
        "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
        "label": "Urine red cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 6,
        "unit": "/[HPF]",
        "reference_range": {
          "high": 2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13945-1",
            "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DSDNA-V4",
        "display": "DNA double strand Ab [Units/volume] in Serum",
        "label": "Anti-dsDNA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 72,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 29
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "5130-0",
            "display": "DNA double strand Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C3-V4",
        "display": "Complement C3 [Mass/volume] in Serum or Plasma",
        "label": "Complement C3",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 84,
        "unit": "mg/dL",
        "reference_range": {
          "low": 90,
          "high": 180
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4485-9",
            "display": "Complement C3 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C4-V4",
        "display": "Complement C4 [Mass/volume] in Serum or Plasma",
        "label": "Complement C4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 13,
        "unit": "mg/dL",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4498-2",
            "display": "Complement C4 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V4",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 36,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V4",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 212,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V4",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 58,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V4",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V4",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 130,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-27",
        "value": 5.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month response assessment for lupus nephritis on mycophenolate, belimumab, hydroxychloroquine, and tapering prednisone.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-27",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic minimal-range depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V4",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Joint pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-07-27",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic joint pain score on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 12.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 5.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V5",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Lymphocytes",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 1.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.8
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 236,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 101,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "high": 33
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-UPCR-V5",
        "display": "Protein/Creatinine [Mass Ratio] in Urine",
        "label": "Urine protein-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 0.35,
        "unit": "g/g",
        "reference_range": {
          "high": 0.2
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2890-2",
            "display": "Protein/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-URBC-V5",
        "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
        "label": "Urine red cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 2,
        "unit": "/[HPF]",
        "reference_range": {
          "high": 2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13945-1",
            "display": "Erythrocytes [#/area] in Urine sediment by Microscopy high power field",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-DSDNA-V5",
        "display": "DNA double strand Ab [Units/volume] in Serum",
        "label": "Anti-dsDNA",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 38,
        "unit": "[IU]/mL",
        "reference_range": {
          "high": 29
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "5130-0",
            "display": "DNA double strand Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C3-V5",
        "display": "Complement C3 [Mass/volume] in Serum or Plasma",
        "label": "Complement C3",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 90,
          "high": 180
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4485-9",
            "display": "Complement C3 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-C4-V5",
        "display": "Complement C4 [Mass/volume] in Serum or Plasma",
        "label": "Complement C4",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 18,
        "unit": "mg/dL",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4498-2",
            "display": "Complement C4 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month response assessment: complete renal response.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic minimal-range depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-PAIN-V5",
        "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
        "label": "Joint pain (0 to 10)",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72514-3",
            "display": "Pain severity - 0-10 verbal numeric rating [Score] - Reported",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic joint pain score in remission.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-SICK",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-15",
        "value": 7.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests at a sick visit on immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "OBS-CREAT-SICK",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-15",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.5,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic same-day tests at a sick visit on immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-SICK",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-15",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium: the first since losartan was started, seven and a half weeks earlier.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-PREV",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic annual depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-PREV",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen: rarely drinks.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Ultrasound-guided percutaneous kidney biopsy: ISN/RPS class III (A) lupus nephritis, endocapillary proliferation in 9 of 30 glomeruli, activity index 6 of 24, chronicity index 1 of 12, full-house immunofluorescence, subendothelial deposits; no crescents, thrombotic microangiopathy, or interstitial fibrosis beyond 10 percent; no bleeding after the procedure",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "438813007",
            "display": "Biopsy of kidney using ultrasound guidance",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-04-24",
          "end": "2026-04-24"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney biopsy for proteinuria above 0.5 g/g with an active urine sediment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Insertion of a levonorgestrel 52 mg intrauterine system, her choice for contraception before mycophenolate; pregnancy test negative",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "65200003",
            "display": "Insertion of intrauterine contraceptive device",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-04-28",
          "end": "2026-04-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic contraception before a teratogenic drug; with negative antiphospholipid antibodies estrogen was also an option.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Bone density scan (DXA) at the start of high-dose glucocorticoids: lumbar spine Z-score -0.4, femoral neck Z-score -0.2; normal for age",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "312681000",
            "display": "Bone density scan",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-04-29",
          "end": "2026-04-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline bone density for glucocorticoid treatment expected to last more than three months.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Baseline eye examination for hydroxychloroquine with dilated fundus examination, spectral-domain optical coherence tomography, and automated 10-2 visual fields: normal; yearly screening from five years of use",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "392010000",
            "display": "Optical coherence tomography",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-06-29",
          "end": "2026-06-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline retinal screening within the first year of hydroxychloroquine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, 2025-2026 season",
        "status": "completed",
        "date": "2025-10-10",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "HPV vaccine, 9-valent, series completed (dose 2 of 2)",
        "status": "completed",
        "date": "2013-10-01",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "165",
            "display": "HPV9",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adolescent immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2019-05-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-04-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination before immunosuppression, recommended for immunocompromised adults.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-04-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination before immunosuppression, recommended from 19 for immunocompromised adults.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-07-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second zoster dose on immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal vaccination; inactivated vaccine is safe on immunosuppression.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "Systemic lupus erythematosus, first diagnosed as rheumatoid arthritis; he died of it in 1941 at 45",
        "condition_coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "M32.9",
            "display": "Systemic lupus erythematosus, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "age_at_death": 45,
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Month-long hospital stay with an operation for a floating kidney",
        "historical_date": {
          "iso": "1949-12",
          "display": "December 1949",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Primary care visit for joint pain and swelling, fevers, fatigue, a facial rash, and protein in the urine in a writer of 25",
        "status": "finished",
        "date": "2026-04-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Diagnosis of systemic lupus erythematosus with the rheumatology consultation the same day; vaccinations before immunosuppression",
        "status": "finished",
        "date": "2026-04-22",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Results of the lupus tests; rheumatology consultation today",
          "hpi": {
            "narrative": "Ms. O'Connor returns nine days after presenting with three months of painful, swollen hands, wrists, and knees, evening fevers, fatigue, a facial rash after sun, and protein and blood in her urine. She saw Dr. Okonjo-Strand this morning, and the tests drawn there returned this afternoon: ANA positive at 1:640 in a homogeneous pattern, anti-dsDNA 186 IU/mL, anti-Sm 42 U/mL, and low complements (C3 62, C4 8 mg/dL). Anticardiolipin and anti-beta-2 glycoprotein I antibodies are negative and the lupus anticoagulant test is negative. The urine protein-to-creatinine ratio is 1.8 g/g, with 22 red cells per high-power field, many of them misshapen, and a red cell cast; creatinine is 0.8. Hepatitis B surface antigen is negative with a positive surface antibody, and hepatitis C and HIV tests are negative; a pregnancy test is negative. Before the results were given she was asked how she wanted to hear them and said she wanted all of it, at once. She was told directly that she has systemic lupus erythematosus, that the urine findings mean the kidneys are probably involved, and that a kidney biopsy is needed to choose treatment; she knows that her father had lupus, and was told plainly that treatment and outlook today are very different. She repeated it back accurately. She asked that her diagnosis not be shared with anyone she has not named.",
            "elements": [
              {
                "label": "Serology",
                "value": "ANA 1:640 homogeneous; anti-dsDNA 186; anti-Sm 42; C3 62, C4 8; antiphospholipid antibodies and lupus anticoagulant negative"
              },
              {
                "label": "Kidney",
                "value": "Protein-to-creatinine ratio 1.8 g/g; active sediment with a red cell cast; creatinine 0.8"
              },
              {
                "label": "Infection screening",
                "value": "Hepatitis B immune by vaccination; hepatitis C and HIV negative"
              },
              {
                "label": "Disclosure",
                "value": "Told the diagnosis directly; teach-back correct; privacy request recorded"
              },
              {
                "label": "Coordination",
                "value": "Rheumatology seen this morning; kidney biopsy in two days"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Evening fevers to 37.8 °C and fatigue"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Painful, swollen hand joints and knees; an hour of morning stiffness"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Facial rash after sun; some hair shedding"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "A painless sore on the roof of the mouth"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No pleuritic chest pain or breathlessness"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No foamy urine noticed; no swelling of the legs"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried but composed; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but engaged; temperature 37.6 °C"
            },
            {
              "system": "Skin",
              "finding": "Red, slightly raised rash over both cheeks and the bridge of the nose, sparing the nasolabial folds; diffuse thinning of the scalp hair"
            },
            {
              "system": "Mouth",
              "finding": "Painless 4 mm ulcer on the hard palate"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Synovitis of the second and third knuckles and middle finger joints of both hands and both wrists; small knee effusions"
            },
            {
              "system": "Cardiovascular",
              "finding": "No rub; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear; no rub"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Systemic lupus erythematosus",
              "assessment": "The positive ANA meets the entry criterion, and the EULAR/ACR weighted classification criteria add up to 32 (fever 2, thrombocytopenia 4, acute cutaneous lupus 6, joint involvement 6, proteinuria above 0.5 g a day 4, low C3 and C4 4, anti-dsDNA or anti-Sm 6), well above the threshold of 10. The disease is highly active (SLEDAI-2K 23). Antiphospholipid antibodies are negative, which matters for contraception and any future pregnancy. This is lupus, not rheumatoid arthritis",
              "plan": [
                "Hydroxychloroquine 300 mg daily now (5 mg/kg), long term",
                "Sun protection every day",
                "No NSAIDs with kidney involvement; acetaminophen for pain",
                "Pneumococcal PCV20 and recombinant zoster vaccine dose 1 today, before immunosuppression"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Proteinuria with an active urine sediment",
              "assessment": "Protein-to-creatinine ratio 1.8 g/g with dysmorphic red cells and a red cell cast: lupus nephritis is likely, and the class determines treatment. Blood pressure 136/84 is above the target of 130/80",
              "plan": [
                "Ultrasound-guided kidney biopsy in two days",
                "Losartan 25 mg daily for proteinuria and blood pressure; potassium and creatinine in two to four weeks"
              ]
            },
            {
              "display": "Contraception before immunosuppression",
              "assessment": "Mycophenolate, the likely treatment, causes birth defects and needs highly effective contraception. With negative antiphospholipid antibodies estrogen-containing methods are not ruled out, but with active disease she chose a levonorgestrel intrauterine system",
              "plan": [
                "Intrauterine system inserted before treatment starts"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Classification: ANA and the EULAR/ACR criteria",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "ANA 1:640; criteria score 32",
              "observation_ids": [
                "OBS-ANA-V2"
              ],
              "guideline_ids": [
                "GL-EULAR-ACR-CRIT-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Anti-dsDNA, anti-Sm, C3, and C4",
              "cadence": "At diagnosis, then every 3 months while active",
              "status": "completed_today",
              "detail": "Anti-dsDNA 186, anti-Sm 42, C3 62, C4 8",
              "observation_ids": [
                "OBS-DSDNA-V2",
                "OBS-SM-V2",
                "OBS-C3-V2",
                "OBS-C4-V2"
              ],
              "guideline_ids": [
                "GL-EULAR-ACR-CRIT-2019"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Antiphospholipid antibodies and lupus anticoagulant",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Anticardiolipin IgG 6 and IgM 4, anti-beta-2 glycoprotein I IgG 3 and IgM 2, dRVVT ratio 1.04: all negative",
              "observation_ids": [
                "OBS-ACLG-V2",
                "OBS-ACLM-V2",
                "OBS-B2GG-V2",
                "OBS-B2GM-V2",
                "OBS-DRVVT-V2"
              ],
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine protein-to-creatinine ratio and urine sediment",
              "cadence": "At diagnosis, then every 3 months",
              "status": "completed_today",
              "detail": "1.8 g/g; 22 red cells per high-power field with dysmorphic cells and a red cell cast",
              "observation_ids": [
                "OBS-UPCR-V2",
                "OBS-URBC-V2"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine and eGFR",
              "cadence": "At diagnosis, then every 3 months",
              "status": "completed_today",
              "detail": "Creatinine 0.8, eGFR 101",
              "observation_ids": [
                "OBS-CREAT-V2",
                "OBS-EGFR-V2"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Nine days ago: white cells 3.3, lymphocytes 0.8, hemoglobin 11.0, platelets 138",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Kidney biopsy",
              "cadence": "When proteinuria is 0.5 g/g or more, or with an active sediment",
              "status": "ordered",
              "detail": "Booked in two days",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C, and HIV screening before immunosuppression",
              "cadence": "Before immunosuppression",
              "status": "completed_today",
              "detail": "Hepatitis B surface antigen negative, surface antibody positive; hepatitis C and HIV negative",
              "guideline_ids": [
                "GL-ACR-VAX-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccinations before immunosuppression",
              "cadence": "Before immunosuppression when possible",
              "status": "completed_today",
              "detail": "PCV20 and recombinant zoster dose 1 today; influenza given in October; COVID-19 due",
              "guideline_ids": [
                "GL-ACR-VAX-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hydroxychloroquine dose and baseline eye examination",
              "cadence": "Dose at start; eye examination within the first year",
              "status": "due",
              "detail": "300 mg daily, 5 mg/kg; ophthalmology booked",
              "guideline_ids": [
                "GL-AAO-HCQ-2016",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "136/84 mmHg, above target; losartan started",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pregnancy test and contraception before mycophenolate",
              "cadence": "Before the first dose",
              "status": "ordered",
              "detail": "Pregnancy test negative today; intrauterine system booked",
              "guideline_ids": [
                "GL-ACR-REPRO-2020",
                "GL-FDA-MMF-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Disclosure and shared decisions",
              "cadence": "At diagnosis and with every result",
              "status": "completed_today",
              "detail": "Told directly; teach-back correct; written summary given",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sun protection",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sunscreen SPF 50, a hat, and midday shade",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis, then periodically",
              "status": "up_to_date",
              "detail": "PHQ-9 7 nine days ago; supportive care",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            }
          ],
          "follow_up": "Kidney biopsy in two days; intrauterine system next week; primary care review with the biopsy result in one week",
          "guideline_ids": [
            "GL-EULAR-ACR-CRIT-2019",
            "GL-EULAR-SLE-2023",
            "GL-ACR-LN-2024",
            "GL-ACR-VAX-2022",
            "GL-ACR-REPRO-2020"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Kidney biopsy result: class III lupus nephritis; start of pulse methylprednisolone, prednisone, mycophenolate, and belimumab",
        "status": "finished",
        "date": "2026-04-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Kidney biopsy result and start of treatment",
          "hpi": {
            "narrative": "Ms. O'Connor had an ultrasound-guided kidney biopsy five days ago without bleeding. It shows ISN/RPS class III (A) lupus nephritis: focal endocapillary proliferation in 9 of 30 glomeruli, activity index 6 of 24, chronicity index 1 of 12, with no crescents or thrombotic microangiopathy. She heard the result from Dr. Okonjo-Strand by telephone two days ago, as she had asked, and again in full today. A levonorgestrel intrauterine system was inserted yesterday. Her joints and rash are unchanged; she has taken hydroxychloroquine and losartan for a week. Today she has the first of three methylprednisolone infusions, starts mycophenolate, and learns to give herself belimumab. She asked how to keep her mornings for writing through treatment.",
            "elements": [
              {
                "label": "Biopsy",
                "value": "Class III (A) lupus nephritis; activity 6 of 24, chronicity 1 of 12"
              },
              {
                "label": "Contraception",
                "value": "Intrauterine system inserted yesterday"
              },
              {
                "label": "Today",
                "value": "Methylprednisolone 500 mg (first of three); mycophenolate; first belimumab injection"
              },
              {
                "label": "Bone",
                "value": "DXA today"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Fatigue; low-grade fevers in the evenings"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Hand and knee pain and swelling unchanged; no hip or groin pain"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Facial rash unchanged"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No pain at the biopsy site; no blood clots in the urine"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Determined; sleeping adequately"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired, composed; temperature 37.0 °C"
            },
            {
              "system": "Back",
              "finding": "Biopsy site clean and healing; no tenderness"
            },
            {
              "system": "Skin",
              "finding": "Malar rash as before"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Synovitis of the hands and wrists as before; full painless hip movement"
            },
            {
              "system": "Cardiovascular",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Class III lupus nephritis",
              "assessment": "Active focal proliferative lupus nephritis with little chronic damage and normal kidney function, so the outlook with treatment is good. Treatment follows the current ACR lupus nephritis guideline: pulse glucocorticoids, then an oral taper, with two other immunosuppressive drugs. She chose mycophenolate with belimumab, given by her own weekly injection at home, rather than mycophenolate with voclosporin, which needs closer kidney and blood pressure monitoring. The goal is a protein-to-creatinine ratio below 0.5 g/g within a year",
              "plan": [
                "Methylprednisolone 500 mg intravenously today and the next two days",
                "Then prednisone 30 mg daily, reduced by 5 mg every two weeks to 10 mg, then to 5 mg or less by six months",
                "Mycophenolate 500 mg twice daily for a week, then 1000 mg twice daily; blood counts weekly for the first month, twice monthly for the next two, then monthly",
                "Belimumab 400 mg weekly for four doses, then 200 mg weekly, by self-injection; report low mood",
                "Pneumocystis prophylaxis discussed and not started, because the prednisone dose falls below 20 mg within six weeks and sulfonamides are avoided in lupus; reconsider if the dose stays high"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Glucocorticoid treatment: bone and avascular necrosis",
              "assessment": "DXA Z-scores -0.4 at the spine and -0.2 at the femoral neck are normal for age, and with no fracture her fracture risk is low, so no osteoporosis drug is needed; vitamin D is low at 26. High-dose glucocorticoids carry a risk of avascular necrosis of the hip",
              "plan": [
                "Vitamin D3 1000 units daily and calcium from food",
                "Report any new hip, groin, or knee pain at once; MRI of the hips if it occurs",
                "Prednisone taken in the morning; watch glucose, blood pressure, sleep, and mood"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Contraception",
              "assessment": "Intrauterine system in place; pregnancy test negative; she can start mycophenolate",
              "plan": [
                "Keep the intrauterine system throughout mycophenolate treatment"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Kidney biopsy",
              "cadence": "Before treatment",
              "status": "up_to_date",
              "detail": "Class III (A); activity 6 of 24; chronicity 1 of 12",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pulse methylprednisolone and oral taper plan",
              "cadence": "At the start of treatment",
              "status": "completed_today",
              "detail": "500 mg today and for two more days; written taper schedule given",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count and liver tests before mycophenolate",
              "cadence": "Before the first dose, then weekly for a month, twice monthly for two months, then monthly",
              "status": "completed_today",
              "detail": "White cells 3.6, lymphocytes 0.9, hemoglobin 11.2, platelets 151; ALT 18",
              "observation_ids": [
                "OBS-WBC-V3",
                "OBS-LYMPH-V3",
                "OBS-HGB-V3",
                "OBS-PLT-V3",
                "OBS-ALT-V3"
              ],
              "guideline_ids": [
                "GL-FDA-MMF-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pregnancy test and contraception before mycophenolate",
              "cadence": "Before the first dose",
              "status": "completed_today",
              "detail": "Pregnancy test negative; intrauterine system inserted yesterday",
              "guideline_ids": [
                "GL-ACR-REPRO-2020",
                "GL-FDA-MMF-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Belimumab start and injection teaching",
              "cadence": "At the start",
              "status": "completed_today",
              "detail": "First 400 mg dose given under supervision; she injected herself; warned to report low mood",
              "guideline_ids": [
                "GL-FDA-BELIMUMAB-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA) at the start of glucocorticoids",
              "cadence": "As soon as possible after starting",
              "status": "completed_today",
              "detail": "Lumbar spine Z-score -0.4; femoral neck Z-score -0.2",
              "observation_ids": [
                "OBS-DXASPZ-V3",
                "OBS-DXAFEMZ-V3"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At the start of glucocorticoids",
              "status": "completed_today",
              "detail": "26 ng/mL; vitamin D3 started",
              "observation_ids": [
                "OBS-VITD-V3"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Avascular necrosis symptoms",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No hip, groin, or knee pain; full hip movement",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hydroxychloroquine baseline eye examination",
              "cadence": "Within the first year",
              "status": "ordered",
              "detail": "Ophthalmology booked in two months",
              "guideline_ids": [
                "GL-AAO-HCQ-2016",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting losartan",
              "cadence": "2 to 4 weeks after starting",
              "status": "due",
              "detail": "Losartan started a week ago; to be drawn with the blood counts in two weeks",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "128/80 mmHg on losartan",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine protein-to-creatinine ratio, sediment, creatinine, anti-dsDNA, and complements",
              "cadence": "Every 3 months during active treatment",
              "status": "due",
              "detail": "At three months",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Recombinant zoster vaccine dose 2",
              "cadence": "1 to 2 months after dose 1",
              "status": "due",
              "detail": "At the three-month visit",
              "guideline_ids": [
                "GL-ACR-VAX-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Writing life and treatment schedule",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Infusions booked in the afternoons; injections at home",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            }
          ],
          "follow_up": "Methylprednisolone tomorrow and the day after. Rheumatology blood counts weekly. Ophthalmology in two months. Three-month review",
          "guideline_ids": [
            "GL-ACR-LN-2024",
            "GL-EULAR-SLE-2023",
            "GL-FDA-MMF-2026",
            "GL-FDA-BELIMUMAB-2026",
            "GL-ACR-GIOP-2022"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three-month response assessment for lupus nephritis and glucocorticoid taper",
        "status": "finished",
        "date": "2026-07-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Three-month review of lupus nephritis",
          "hpi": {
            "narrative": "Ms. O'Connor is thirteen weeks into treatment. Her joint pain and swelling settled within three weeks and the facial rash has faded with sun protection; she has had no fevers. She takes prednisone 10 mg a day, reached a month ago, mycophenolate 1000 mg twice daily (loose stools in the first two weeks, since settled), weekly belimumab by her own injection, hydroxychloroquine, and losartan. The rheumatology blood counts, weekly for the first month and twice monthly since, have stayed normal, with white cells between 4.8 and 7.9 and normal liver tests. The bladder infection in June grew Escherichia coli sensitive to nitrofurantoin and cleared after seven days. Her baseline eye examination a month ago was normal. She has gained 3.4 kg and sleeps less well on the days after a dose reduction. She writes five mornings a week.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Arthritis, rash, and fevers resolved; cystitis in June resolved"
              },
              {
                "label": "Medicines",
                "value": "Prednisone 10 mg; mycophenolate 2 g a day; belimumab weekly; hydroxychloroquine; losartan"
              },
              {
                "label": "Monitoring",
                "value": "Blood counts and liver tests normal; eye examination normal"
              },
              {
                "label": "Work",
                "value": "Writing five mornings a week"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Weight up 3.4 kg; no fever"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain; no hip, groin, or knee pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Rash gone; hair shedding less"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Stools normal now"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Poor sleep on some nights; mood good; PHQ-9 4"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; slight fullness of the face"
            },
            {
              "system": "Skin",
              "finding": "No malar rash; no mouth ulcers"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No synovitis; full, painless hip movement"
            },
            {
              "system": "Cardiovascular",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Class III lupus nephritis on treatment",
              "assessment": "The protein-to-creatinine ratio has halved, from 1.8 to 0.9 g/g, with fewer red cells (6 per high-power field) and stable creatinine 0.8. Anti-dsDNA has fallen from 186 to 72 and complements are rising (C3 84, C4 13). She is responding and on track for a complete response",
              "plan": [
                "Continue mycophenolate 1000 mg twice daily, belimumab weekly, hydroxychloroquine, and losartan",
                "Prednisone to 7.5 mg next month and 5 mg by six months",
                "Blood counts monthly from now"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Systemic lupus erythematosus",
              "assessment": "Clinically quiet outside the kidney. Cardiovascular risk: LDL 128 mg/dL, total cholesterol 212, HDL 58 on prednisone; HbA1c 5.3 percent; blood pressure 122/78; never smoker",
              "plan": [
                "No statin now; recheck lipids at one year on a low prednisone dose",
                "Recombinant zoster vaccine dose 2 today"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Glucocorticoids: bone and side effects",
              "assessment": "Vitamin D 36 on replacement; no hip pain; weight gain and poor sleep expected to ease as the dose falls",
              "plan": [
                "Continue vitamin D3",
                "Report any hip, groin, or knee pain at once"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Urine protein-to-creatinine ratio and urine sediment",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "0.9 g/g, from 1.8; 6 red cells per high-power field",
              "observation_ids": [
                "OBS-UPCR-V4",
                "OBS-URBC-V4"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR, and albumin",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "Creatinine 0.8, eGFR 101, albumin 3.8",
              "observation_ids": [
                "OBS-CREAT-V4",
                "OBS-EGFR-V4",
                "OBS-ALB-V4"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Anti-dsDNA, C3, and C4",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "Anti-dsDNA 72; C3 84; C4 13",
              "observation_ids": [
                "OBS-DSDNA-V4",
                "OBS-C3-V4",
                "OBS-C4-V4"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count and liver tests on mycophenolate",
              "cadence": "Weekly for a month, twice monthly for two months, then monthly",
              "status": "completed_today",
              "detail": "White cells 5.2, lymphocytes 1.0, hemoglobin 12.1, platelets 212; ALT 22; earlier rheumatology counts normal",
              "observation_ids": [
                "OBS-WBC-V4",
                "OBS-LYMPH-V4",
                "OBS-HGB-V4",
                "OBS-PLT-V4",
                "OBS-ALT-V4"
              ],
              "guideline_ids": [
                "GL-FDA-MMF-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine after starting losartan",
              "cadence": "2 to 4 weeks after starting",
              "status": "deferred",
              "detail": "Missed, a deviation from the protocol: the check due two to four weeks after losartan was started was not drawn, because the standing rheumatology orders were for blood counts only. The first potassium, at the sick visit seven and a half weeks after starting, was 4.6 with creatinine unchanged at 0.8, so no harm resulted. Corrective action: a basic metabolic panel was added to the standing orders at that visit, and any dose change will be followed by a check at two weeks",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium",
              "cadence": "With each kidney panel on losartan",
              "status": "completed_today",
              "detail": "4.4 mmol/L",
              "observation_ids": [
                "OBS-K-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "122/78 mmHg, at target",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose and lipids on glucocorticoids",
              "cadence": "At three months",
              "status": "completed_today",
              "detail": "HbA1c 5.3 percent; total cholesterol 212, HDL 58, LDL 128, triglycerides 130",
              "observation_ids": [
                "OBS-A1C-V4",
                "OBS-CHOL-V4",
                "OBS-HDL-V4",
                "OBS-LDL-V4",
                "OBS-TG-V4"
              ],
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "After repletion",
              "status": "completed_today",
              "detail": "36 ng/mL",
              "observation_ids": [
                "OBS-VITD-V4"
              ],
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Avascular necrosis symptoms",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No hip, groin, or knee pain",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Glucocorticoid dose",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Prednisone 10 mg; on schedule for 5 mg or less by six months",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hydroxychloroquine baseline eye examination",
              "cadence": "Within the first year",
              "status": "up_to_date",
              "detail": "A month ago: fundus, OCT, and visual fields normal",
              "guideline_ids": [
                "GL-AAO-HCQ-2016",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Recombinant zoster vaccine dose 2",
              "cadence": "1 to 2 months after dose 1",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-ACR-VAX-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception on mycophenolate",
              "cadence": "Every visit",
              "status": "up_to_date",
              "detail": "Intrauterine system in place",
              "guideline_ids": [
                "GL-ACR-REPRO-2020",
                "GL-FDA-MMF-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood on belimumab (PHQ-9)",
              "cadence": "Periodically",
              "status": "completed_today",
              "detail": "PHQ-9 4",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-FDA-BELIMUMAB-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Joint pain score",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "1 of 10",
              "observation_ids": [
                "OBS-PAIN-V4"
              ],
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sun protection and writing schedule",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sunscreen daily; writing five mornings a week",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            }
          ],
          "follow_up": "Prednisone to 7.5 mg next month. Rheumatology blood counts monthly. Preventive visit in October. Six-month review",
          "guideline_ids": [
            "GL-ACR-LN-2024",
            "GL-EULAR-SLE-2023",
            "GL-FDA-MMF-2026",
            "GL-CMID-2026",
            "GL-ACR-GIOP-2022"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month response assessment: complete renal response; prednisone 5 mg; pregnancy planning",
        "status": "finished",
        "date": "2026-10-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Six-month review of lupus nephritis; pregnancy planning",
          "hpi": {
            "narrative": "Ms. O'Connor is six months into treatment. She reached prednisone 5 mg a day a week ago. Her joints and skin remain quiet; she has had no fevers, infections, or hip pain since the summer. Monthly blood counts have been normal. She had her influenza vaccine at the preventive visit three weeks ago. She has finished a draft of her novel. She would like to have children in a few years and asked what that would mean for her treatment.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Prednisone 5 mg a day; no flares or infections"
              },
              {
                "label": "Medicines",
                "value": "Mycophenolate 2 g a day; belimumab weekly; hydroxychloroquine 300 mg; losartan 25 mg; vitamin D3"
              },
              {
                "label": "Question",
                "value": "Pregnancy in a few years"
              },
              {
                "label": "Work",
                "value": "Draft of her novel finished"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight falling"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain; no hip, groin, or knee pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash; hair regrowing"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 3"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well"
            },
            {
              "system": "Skin",
              "finding": "No rash; no mouth ulcers"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No synovitis; full, painless hip movement"
            },
            {
              "system": "Cardiovascular",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Class III lupus nephritis",
              "assessment": "Complete renal response at six months: protein-to-creatinine ratio 0.35 g/g, red cells 2 per high-power field, creatinine 0.8. Anti-dsDNA 38 and complements normal (C3 96, C4 18). Treatment continues for three to five years after a complete response before any reduction",
              "plan": [
                "Continue mycophenolate, belimumab, hydroxychloroquine, and losartan",
                "Prednisone 5 mg; withdrawal to be considered after a further period of quiet disease",
                "Kidney panel, urine protein, and serology every three months"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Pregnancy planning",
              "assessment": "Pregnancy is possible and safest after at least six months of quiet disease on pregnancy-compatible medicines. Her negative antiphospholipid tests mean no heparin is expected. Lupus nephritis raises the risk of preeclampsia",
              "plan": [
                "When she is ready: switch mycophenolate to azathioprine and stop losartan, with at least six weeks off mycophenolate before trying and a period of stability on azathioprine first",
                "Continue hydroxychloroquine through pregnancy; belimumab reviewed with her rheumatologist before conception",
                "Anti-Ro and anti-La antibodies before pregnancy; low-dose aspirin from 12 weeks; joint care with obstetrics",
                "Keep the intrauterine system until then"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Glucocorticoids: bone",
              "assessment": "No hip pain; vitamin D replete",
              "plan": [
                "Repeat DXA in one to two years while on glucocorticoids"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Urine protein-to-creatinine ratio and urine sediment",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "0.35 g/g; 2 red cells per high-power field: complete renal response",
              "observation_ids": [
                "OBS-UPCR-V5",
                "OBS-URBC-V5"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Creatinine, eGFR, albumin, and potassium",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "Creatinine 0.8, eGFR 101, albumin 4.1, potassium 4.3",
              "observation_ids": [
                "OBS-CREAT-V5",
                "OBS-EGFR-V5",
                "OBS-ALB-V5",
                "OBS-K-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Anti-dsDNA, C3, and C4",
              "cadence": "Every 3 months during active treatment",
              "status": "completed_today",
              "detail": "Anti-dsDNA 38; C3 96; C4 18",
              "observation_ids": [
                "OBS-DSDNA-V5",
                "OBS-C3-V5",
                "OBS-C4-V5"
              ],
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count and liver tests on mycophenolate",
              "cadence": "Monthly in the first year",
              "status": "completed_today",
              "detail": "White cells 5.6, lymphocytes 1.2, hemoglobin 12.8, platelets 236; ALT 20",
              "observation_ids": [
                "OBS-WBC-V5",
                "OBS-LYMPH-V5",
                "OBS-HGB-V5",
                "OBS-PLT-V5",
                "OBS-ALT-V5"
              ],
              "guideline_ids": [
                "GL-FDA-MMF-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "118/76 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Glucocorticoid dose",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Prednisone 5 mg a day at six months, as planned",
              "guideline_ids": [
                "GL-ACR-LN-2024",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Avascular necrosis symptoms",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No hip, groin, or knee pain",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Bone density (DXA)",
              "cadence": "Every 1 to 3 years on glucocorticoids",
              "status": "up_to_date",
              "detail": "Normal six months ago",
              "guideline_ids": [
                "GL-ACR-GIOP-2022",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Hydroxychloroquine eye screening",
              "cadence": "Yearly from five years of use",
              "status": "up_to_date",
              "detail": "Baseline normal four months ago",
              "guideline_ids": [
                "GL-AAO-HCQ-2016",
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccinations",
              "cadence": "Yearly influenza; others as due",
              "status": "up_to_date",
              "detail": "Influenza three weeks ago; PCV20 and two zoster doses done; COVID-19 booked",
              "guideline_ids": [
                "GL-ACR-VAX-2022",
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception and pregnancy planning",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Intrauterine system in place; pregnancy plan discussed",
              "guideline_ids": [
                "GL-ACR-REPRO-2020",
                "GL-FDA-MMF-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Anti-Ro and anti-La antibodies",
              "cadence": "Before pregnancy",
              "status": "due",
              "detail": "When she plans a pregnancy",
              "guideline_ids": [
                "GL-ACR-REPRO-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipids",
              "cadence": "Yearly on glucocorticoids",
              "status": "due",
              "detail": "At one year",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood on belimumab (PHQ-9)",
              "cadence": "Periodically",
              "status": "completed_today",
              "detail": "PHQ-9 3",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-FDA-BELIMUMAB-2026",
                "GL-ACR-LN-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Joint pain score",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "0 of 10",
              "observation_ids": [
                "OBS-PAIN-V5"
              ],
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sun protection and writing schedule",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sunscreen daily; draft of her novel finished",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            }
          ],
          "follow_up": "Rheumatology every three months with kidney panel, urine protein, and serology. Blood counts monthly to one year. Primary care review in three months",
          "guideline_ids": [
            "GL-ACR-LN-2024",
            "GL-EULAR-SLE-2023",
            "GL-ACR-REPRO-2020",
            "GL-FDA-MMF-2026",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for bladder symptoms on immunosuppression",
        "status": "finished",
        "date": "2026-06-15",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Burning on passing urine and going often for two days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Ms. O'Connor is a 25-year-old writer with systemic lupus erythematosus and class III lupus nephritis, seven weeks into treatment with mycophenolate 1000 mg twice daily, weekly belimumab, hydroxychloroquine, losartan, and prednisone, now 15 mg a day. For two days she has had burning on passing urine, frequency, urgency, and lower abdominal discomfort. She has no fever on her home thermometer, chills, back or flank pain, vomiting, vaginal discharge, or rash, and her joints are quiet. She has a levonorgestrel intrauterine system. She called because she had been told that any infection on her treatment should be seen the same day, and she wanted to know whether this was her kidneys.",
            "elements": [
              {
                "label": "Onset",
                "value": "Two days ago"
              },
              {
                "label": "Location",
                "value": "Bladder; no flank pain"
              },
              {
                "label": "Duration",
                "value": "Two days"
              },
              {
                "label": "Character",
                "value": "Burning, frequency, urgency"
              },
              {
                "label": "Severity",
                "value": "Moderate; writing still"
              },
              {
                "label": "Context",
                "value": "Mycophenolate, belimumab, and prednisone 15 mg; intrauterine system"
              },
              {
                "label": "Modifying factors",
                "value": "Extra fluids help a little"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No fever, chills, flank pain, vomiting, or discharge"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or chills"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Dysuria, frequency, urgency, suprapubic discomfort; no flank pain or discharge"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No vomiting or diarrhea"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain or swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well-appearing; temperature 37.3 °C, pulse 84/min"
            },
            {
              "system": "Abdomen",
              "finding": "Mild suprapubic tenderness; no masses"
            },
            {
              "system": "Back",
              "finding": "No costovertebral angle tenderness"
            },
            {
              "system": "Skin",
              "finding": "No malar rash; no lesions"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No joint swelling or tenderness"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-008",
              "display": "Acute cystitis in an immunosuppressed woman",
              "assessment": "Typical bladder symptoms with leukocyte esterase and nitrite on the dipstick, no fever, and no flank tenderness: cystitis without signs of kidney infection. Prednisone can hide fever, so the threshold to treat and to culture is low. White cell count 7.9, creatinine 0.8 unchanged. Nitrofurantoin is first-line with her normal kidney function; trimethoprim-sulfamethoxazole is avoided because sulfonamides can provoke lupus flares and drug reactions",
              "plan": [
                "Urine culture sent before the first dose",
                "Nitrofurantoin 100 mg twice daily with food for seven days, a longer course because she is immunosuppressed",
                "Same-day call for fever, chills, flank pain, or vomiting, which would need assessment for kidney infection",
                "Urine protein-to-creatinine ratio and sediment not measured today, since infection distorts both; they will be repeated at the three-month visit after the infection clears"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Lupus nephritis on treatment",
              "assessment": "No sign of a flare: joints quiet, no rash, creatinine stable. Potassium 4.6, normal, is the first potassium since losartan was started",
              "plan": [
                "Continue mycophenolate, belimumab, hydroxychloroquine, losartan, and the prednisone taper without change",
                "Basic metabolic panel added to the standing blood count orders"
              ]
            }
          ],
          "follow_up": "Culture result by telephone in two days. Rheumatology blood count as scheduled. Three-month review in six weeks",
          "guideline_ids": [
            "GL-IDSA-UTI-2010",
            "GL-ACR-LN-2024",
            "GL-EULAR-SLE-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Adult preventive visit",
        "status": "finished",
        "date": "2026-10-05",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Adult preventive visit; no new complaints",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day",
          "hpi": {
            "narrative": "Ms. O'Connor returns for her yearly preventive visit, five months into treatment for lupus nephritis. Her joints and skin are quiet, and the three-month results showed the urine protein falling by half. She is on prednisone 7.5 mg a day, tapering. The bladder infection in June cleared with nitrofurantoin. She writes five mornings a week and has finished a draft of her novel. She completed the health risk assessment before the visit.",
            "elements": [
              {
                "label": "Visit",
                "value": "Adult preventive visit, age 25"
              },
              {
                "label": "Active conditions",
                "value": "Systemic lupus erythematosus with class III lupus nephritis on treatment"
              },
              {
                "label": "Medicines",
                "value": "Mycophenolate 1000 mg twice daily; belimumab 200 mg weekly; hydroxychloroquine 300 mg daily; losartan 25 mg daily; prednisone 7.5 mg daily, tapering; vitamin D3 1000 units daily"
              },
              {
                "label": "Recent events",
                "value": "Cystitis in June, resolved"
              },
              {
                "label": "Functional status",
                "value": "Independent; no morning stiffness"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and much better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by friends and her writing community; feels safe; health insurance covers her medicines"
            },
            {
              "domain": "Behavioral",
              "finding": "Never smoker; alcohol rarely; walks most days; sunscreen and a hat outdoors"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in all"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Manages her medicines, injections, money, and correspondence"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "One long-term partner; intrauterine system in place; not planning pregnancy this year"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors working; wears a seat belt; gloves and a mask when cleaning the bird pens"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Baseline eye examination for hydroxychloroquine in June normal; hearing normal"
            },
            {
              "domain": "Sleep",
              "finding": "Eight hours; less fatigue"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight stable after a small gain on prednisone"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth ulcers"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or pleuritic pain"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No diarrhea or abdominal pain on mycophenolate"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms; light periods with the intrauterine system"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain; no hip, groin, or knee pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash; hair regrowing"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headaches or seizures"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well-appearing; BMI 22.0"
            },
            {
              "system": "Eyes",
              "finding": "Pupils equal and reactive"
            },
            {
              "system": "Mouth",
              "finding": "No ulcers; teeth in good repair"
            },
            {
              "system": "Neck",
              "finding": "No nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur or rub; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Musculoskeletal",
              "finding": "No synovitis; full, painless hip movement"
            },
            {
              "system": "Skin",
              "finding": "No malar or discoid rash; no suspicious moles"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and funny"
            }
          ],
          "assessment_plan": [
            {
              "display": "Adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and a written prevention plan given. Depression screen negative; AUDIT-C 1",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Systemic lupus erythematosus on immunosuppression",
              "assessment": "Clinically quiet. Infection prevention is complete for the year with today's influenza vaccine; COVID-19 vaccine due",
              "plan": [
                "Continue the rheumatology plan; six-month assessment this month"
              ]
            },
            {
              "display": "Cervical cancer screening while immunosuppressed",
              "assessment": "Cytology two years ago was normal. Women on immunosuppression have a higher risk of cervical precancer, so yearly screening is advised while she is on mycophenolate",
              "plan": [
                "Cervical cytology with HPV testing today; result by portal message"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine, 2026-2027",
              "status": "completed_today",
              "detail": "Inactivated vaccine given today; live vaccines are avoided on immunosuppression",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-ACR-VAX-2022"
              ]
            },
            {
              "service": "COVID-19 vaccine, 2026-2027",
              "status": "due",
              "detail": "Recommended; booked at her pharmacy next week",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 in April, recommended for immunocompromised adults; no further doses",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "up_to_date",
              "detail": "Two doses, in April and July, recommended from 19 for immunocompromised adults",
              "guideline_ids": [
                "GL-CDC-IMZ-MC-2026",
                "GL-ACR-VAX-2022"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "up_to_date",
              "detail": "Series completed in adolescence"
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "up_to_date",
              "detail": "Vaccinated in infancy; surface antibody positive and surface antigen negative in April",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus booster",
              "status": "up_to_date",
              "detail": "Tdap seven years ago"
            },
            {
              "service": "Cervical cancer screening",
              "status": "ordered",
              "detail": "Cytology with HPV testing today, yearly while immunosuppressed",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C and HIV screening",
              "status": "up_to_date",
              "detail": "Negative in April, before immunosuppression",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Chlamydia and gonorrhea screening",
              "status": "not_indicated",
              "detail": "Age 25 with one long-term partner; offered if risk changes",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Contraception",
              "status": "up_to_date",
              "detail": "Levonorgestrel intrauterine system since April; required while on mycophenolate",
              "guideline_ids": [
                "GL-ACR-REPRO-2020"
              ]
            },
            {
              "service": "Folic acid",
              "status": "completed_today",
              "detail": "Advised 0.4 mg daily, as for all who could become pregnant",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "116/74 mmHg on losartan"
            },
            {
              "service": "Cholesterol and diabetes",
              "status": "up_to_date",
              "detail": "LDL 128 mg/dL and HbA1c 5.3 percent in July on prednisone; no statin; recheck at one year on a low dose"
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 1, negative",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Skin cancer prevention and sun protection",
              "status": "completed_today",
              "detail": "Daily broad-spectrum sunscreen and a hat, also for lupus photosensitivity",
              "guideline_ids": [
                "GL-EULAR-SLE-2023"
              ]
            },
            {
              "service": "Physical activity and diet counseling",
              "status": "completed_today",
              "detail": "Walking most days; calcium-rich foods; low salt for blood pressure and the kidneys"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 15 minutes, with her consent. She has named a close friend as her health care agent and completed a written health care directive today, now scanned into the chart. Her first instruction is that she is to be told the truth about her illness directly, and that no clinician is to give her information to anyone else before giving it to her. She would want full treatment for a lupus flare or an infection; she would not want prolonged life support if she could not expect to recover the ability to read and write.",
          "follow_up": "Cervical screening result by portal message. Six-month lupus nephritis assessment this month. COVID-19 vaccine next week",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-04-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 60.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 96,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.9,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-04-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 59.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.0,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-07-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 63.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-06-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.3,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 168,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 62.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs; no measurement from her lifetime is recorded in the cited sources.",
          "author": "The Human Record generator",
          "created": "2026-11-06T00:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Occupation: writer; finishing her first novel after a graduate writing program; writes every morning for about three hours and protects that time",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0016"
          ],
          "synthetic_reason": "Synthetic modern occupation echoing her documented work; not a historical assertion about her schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Never smoker; rarely drinks alcohol; no other substances",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern substance-use history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives in a rented room in a friend's house in the country while she writes; spends much time outdoors and with birds",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern living situation; no relative or friend is a source of history or a decision-maker.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Strengths: a sharp, ironic sense of humor and a steady religious faith; supports: friends and a writing community; she prefers to keep her health out of conversations about her work",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic strengths and supports; the people are unnamed.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Reproductive history: no pregnancies; regular periods; sexually active with no current contraception; would like children some day but not now",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern reproductive history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent; morning stiffness makes buttons and typing hard for the first hour; writing sessions cut short by fatigue",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, witty, and direct; asks for exact answers",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood worn down by fatigue; PHQ-9 7; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Inflammatory polyarthritis with fevers, fatigue, a malar-pattern rash, leukopenia, lymphopenia, mild anemia and thrombocytopenia, and protein and blood in the urine in a woman of 25. I suspect systemic lupus erythematosus with kidney involvement rather than rheumatoid arthritis. Please confirm the diagnosis, assess the kidneys, and plan treatment with her",
        "urgency": "Urgent, within ten days, because of the urine findings",
        "pertinent_history": "Three months of pain and swelling in the small joints of both hands, the wrists, and the knees, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; she was told elsewhere it might be rheumatoid arthritis. Today: temperature 37.9 °C, blood pressure 138/86. White cells 3.3, lymphocytes 0.8, hemoglobin 11.0, platelets 138; creatinine 0.8, eGFR 101, albumin 3.3; ESR 52, CRP 0.6; urine protein-to-creatinine ratio 1.6 g/g with 18 red cells per high-power field. PHQ-9 7. An operation for a floating kidney some years ago. Her father had lupus. No medicines except acetaminophen as needed; no NSAIDs advised. No known allergy. Sexually active without contraception; would like children some day. She is a writer finishing her first novel. She asks for plain, complete answers, given to her directly, and that her diagnosis not be shared with anyone she has not named",
        "questions": [
          "Does she have systemic lupus erythematosus, and which tests confirm it and define organ involvement?",
          "Do the urine findings mean lupus nephritis, and does she need a kidney biopsy?",
          "What treatment do you recommend, including hydroxychloroquine, how to keep glucocorticoids low, and which immunosuppressive or biologic drugs?",
          "Which vaccinations and infection screening should come before immunosuppression?",
          "What contraception is suitable, and how should a future pregnancy be planned?",
          "How should bone health, avascular necrosis, and the eyes be protected and monitored?",
          "She knows that her father had lupus: how should that family history shape her counseling?"
        ]
      },
      "consultant_note": {
        "history": "Ms. O'Connor is seen at the request of Dr. Pemberton-Diallo. For three months she has had symmetrical pain and swelling of the hand joints, wrists, and knees with an hour of morning stiffness, evening fevers, fatigue, a facial rash after sun, some hair shedding, and a painless sore on the roof of her mouth. She has no chest pain on breathing, breathlessness, leg swelling, seizures, or headaches. She had an operation for a floating kidney some years ago. Her father had lupus. She takes only acetaminophen. She asked to hear everything directly and plainly",
        "data_reviewed": "Dr. Pemberton-Diallo's referral and the blood and urine tests from nine days ago; the ANA, anti-dsDNA, anti-Sm, complements, antiphospholipid antibodies, lupus anticoagulant, repeat urine protein-to-creatinine ratio, and urine microscopy drawn here this morning, which returned this afternoon; hepatitis B, hepatitis C, HIV, and pregnancy tests",
        "exam": [
          {
            "system": "Skin",
            "finding": "Red, slightly raised rash over both cheeks and the bridge of the nose, sparing the nasolabial folds; diffuse thinning of the scalp hair"
          },
          {
            "system": "Mouth",
            "finding": "Painless 4 mm ulcer on the hard palate"
          },
          {
            "system": "Musculoskeletal",
            "finding": "Synovitis of the second and third knuckles and middle finger joints of both hands and both wrists; small knee effusions; no deformity"
          },
          {
            "system": "Cardiovascular and respiratory",
            "finding": "No rub; chest clear; no edema"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-003",
            "display": "Systemic lupus erythematosus",
            "assessment": "ANA 1:640 meets the EULAR/ACR entry criterion, and the weighted criteria score 32 (fever, thrombocytopenia, acute cutaneous lupus, joint involvement, proteinuria, low C3 and C4, anti-dsDNA and anti-Sm), so she is classified as having lupus; anti-dsDNA 186 and anti-Sm 42 are highly specific. Disease activity is high (SLEDAI-2K 23). The arthritis of lupus mimics rheumatoid arthritis, which is why it is often misnamed. Antiphospholipid antibodies and lupus anticoagulant are negative"
          },
          {
            "problem_id": "PRB-002",
            "display": "Kidney involvement",
            "assessment": "A protein-to-creatinine ratio of 1.8 g/g with dysmorphic red cells and a red cell cast and normal creatinine almost certainly means lupus nephritis. A kidney biopsy is needed now, because the class decides treatment"
          },
          {
            "display": "Treatment",
            "assessment": "Hydroxychloroquine for every patient with lupus, at 5 mg/kg or less, now. If the biopsy shows class III or IV nephritis: three days of pulse methylprednisolone, then prednisone from about 0.5 mg/kg tapered to 5 mg a day or less by six months, with mycophenolate 2 to 3 g a day plus a second agent, either belimumab or a calcineurin inhibitor such as voclosporin, continued for years after a complete response. An angiotensin receptor blocker for proteinuria and blood pressure. If the class were V alone, the plan would change"
          },
          {
            "display": "Vaccination and infection",
            "assessment": "Non-live vaccines are best given before immunosuppression: PCV20 and recombinant zoster can be given today and influenza was given in October. She is immune to hepatitis B by vaccination and negative for hepatitis C and HIV. Pneumocystis prophylaxis can be considered while the prednisone dose is high; sulfonamides are best avoided in lupus"
          },
          {
            "display": "Contraception and pregnancy",
            "assessment": "Mycophenolate causes birth defects and needs highly effective contraception. With negative antiphospholipid tests, estrogen is not contraindicated by clotting risk, but an intrauterine system is the most effective choice during active disease. Pregnancy should wait for at least six months of quiet disease on compatible medicines"
          },
          {
            "display": "Bone, avascular necrosis, and eyes",
            "assessment": "High-dose glucocorticoids threaten bone and can cause avascular necrosis of the hip, especially at high doses. A DXA at the start, vitamin D and calcium, and the lowest glucocorticoid dose protect her; new hip, groin, or knee pain needs prompt MRI. Hydroxychloroquine needs a baseline eye examination with OCT and visual fields within the first year"
          },
          {
            "display": "Family history",
            "assessment": "Lupus clusters in families, and first-degree relatives have a much higher relative risk, although the absolute risk to any one relative is low. No genetic test is needed. She was told that treatment and outcomes today are very different from those of earlier generations"
          }
        ],
        "recommendations": [
          "Hydroxychloroquine 300 mg daily now, long term; baseline eye examination within the first year, then yearly from five years",
          "Ultrasound-guided kidney biopsy within days",
          "For class III or IV nephritis: methylprednisolone 500 mg daily for three days, then prednisone 30 mg tapered to 5 mg or less by six months; mycophenolate mofetil, 500 mg twice daily for a week, then 1000 mg twice daily; and belimumab or voclosporin, chosen with her",
          "Losartan 25 mg daily, with potassium and creatinine in two to four weeks; blood pressure below 130/80",
          "PCV20 and recombinant zoster dose 1 today, zoster dose 2 in one to two months, seasonal influenza and COVID-19; no live vaccines",
          "Levonorgestrel intrauterine system before mycophenolate, with a negative pregnancy test",
          "DXA at the start of glucocorticoids, vitamin D3 and dietary calcium; report hip, groin, or knee pain",
          "Daily sun protection; no NSAIDs; blood counts weekly for the first month on mycophenolate, then less often; urine protein, sediment, creatinine, and serology every three months",
          "Every result to be explained to her directly, with a written copy, and shared only with the people she names"
        ],
        "communication": "Discussed with Dr. Pemberton-Diallo the same day. Ms. O'Connor was told the diagnosis directly, has a written summary, and agreed to the biopsy and the plan; she will hear the biopsy result from this clinic by telephone first",
        "follow_up": "Kidney biopsy in two days; this clinic will give her the result and start treatment at the primary care visit in one week, then see her every three months with weekly blood counts in the first month"
      },
      "guideline_ids": [
        "GL-EULAR-ACR-CRIT-2019",
        "GL-EULAR-SLE-2023",
        "GL-ACR-LN-2024",
        "GL-ACR-VAX-2022",
        "GL-ACR-REPRO-2020",
        "GL-ACR-GIOP-2022",
        "GL-AAO-HCQ-2016"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Painful, swollen hands and knees, fevers, tiredness, and a rash on her face, for three months",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic presenting concern; joint pain in 1950 is documented.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "Wants a plain, complete answer about what is wrong, told to her directly, and asks that it not be shared with anyone she has not named",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "Afraid of losing her writing mornings to illness or treatment",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern echoing her documented work.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Establish the diagnosis within two weeks and hear it directly, in plain words",
        "status": "completed",
        "target_date": "2026-04-22",
        "outcome": "Told directly at nine days that she has systemic lupus erythematosus, with the reasons and a written summary",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic and disclosure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Renal response: urine protein-to-creatinine ratio halved by three months and below 0.5 g/g with stable kidney function by six to twelve months",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "Ratio 1.8 at diagnosis, 0.9 at three months, 0.35 at six months, a complete response; creatinine 0.8 throughout",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lupus nephritis target.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Prednisone 5 mg a day or less by six months, with withdrawal considered later",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "5 mg a day at six months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic glucocorticoid-sparing goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Write at least four mornings a week through treatment",
        "status": "active",
        "target_date": "2026-12-31",
        "outcome": "Writing five mornings a week by three months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic goal for her work.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "No unplanned pregnancy on mycophenolate; plan any pregnancy for a time of quiet disease on compatible medicines",
        "status": "active",
        "target_date": "2026-12-31",
        "outcome": "Intrauterine system in place; pregnancy planning discussed",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive-health goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Inflammatory arthritis with fever, rash, cytopenias, and an abnormal urine: blood count, chemistry, ESR and CRP, urine microscopy and protein-to-creatinine ratio today; ANA, anti-dsDNA, anti-Sm, complements, and antiphospholipid antibodies; no NSAIDs with protein in the urine",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-ACR-CRIT-2019",
          "GL-ACR-LN-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic diagnostic pathway.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Rheumatology consultation within ten days, to confirm the diagnosis, stage organ involvement, and plan treatment with her",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Disclosure: every result explained to her directly and in plain words, with a written copy; her health shared only with the people she names",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic communication plan; the contrast with the documented concealment of her diagnosis is the teaching point.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Sun protection: broad-spectrum sunscreen SPF 50 or higher, a wide-brimmed hat, and shade in the middle of the day",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic photoprotection.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Hydroxychloroquine 300 mg daily (5 mg/kg) for every patient with lupus, long term, with a baseline eye examination within the first year and yearly screening after five years",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023",
          "GL-AAO-HCQ-2016"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antimalarial treatment and retinal safety.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-006",
        "display": "Kidney biopsy for proteinuria above 0.5 g/g with an active sediment, to class the nephritis before treatment",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-LN-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney biopsy.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-007",
        "display": "Vaccinations before immunosuppression: PCV20 and recombinant zoster dose 1 now, zoster dose 2 after one to two months, seasonal influenza and COVID-19; no live vaccines on immunosuppression; hepatitis B, hepatitis C, and HIV screening",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-VAX-2022",
          "GL-CDC-IMZ-MC-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic infection prevention.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-008",
        "display": "Angiotensin receptor blocker (losartan) for proteinuria and blood pressure, target below 130/80 mmHg, with potassium and creatinine two to four weeks after starting",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-LN-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney protection.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-009",
        "display": "Contraception before mycophenolate: highly effective method of her choice (levonorgestrel intrauterine system); pregnancy test before starting; pregnancy planning later for at least six months of quiet disease on pregnancy-compatible medicines",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-REPRO-2020",
          "GL-FDA-MMF-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive health plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-010",
        "display": "Class III lupus nephritis: methylprednisolone 500 mg daily for three days, then prednisone 30 mg tapered to 5 mg a day or less by six months; mycophenolate mofetil 2 g a day with belimumab, continued for three to five years after a complete response; blood counts weekly for the first month, twice monthly for the next two, then monthly; urine protein-to-creatinine ratio, urine sediment, creatinine, anti-dsDNA, and complements every three months",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-LN-2024",
          "GL-EULAR-SLE-2023",
          "GL-FDA-MMF-2026",
          "GL-FDA-BELIMUMAB-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic initial and continuing nephritis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-29"
      },
      {
        "id": "INT-011",
        "display": "Bone protection on glucocorticoids: baseline DXA, vitamin D3 and calcium from food, weight-bearing exercise; report new hip, groin, or knee pain at once so avascular necrosis can be looked for with MRI",
        "status": "completed",
        "guideline_ids": [
          "GL-ACR-GIOP-2022",
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic bone and avascular necrosis plan; the documented steroid bone damage in her life is the reason.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-29"
      },
      {
        "id": "INT-012",
        "display": "Cardiovascular risk: blood pressure at every visit, lipids and HbA1c at three months on glucocorticoids, no smoking, activity, and a lower glucocorticoid dose",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular protection.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-29"
      },
      {
        "id": "INT-013",
        "display": "Writing life: treatment visits and infusions booked in the afternoons, belimumab self-injected at home, fatigue managed with graded activity and sleep; her illness kept out of conversations about her work unless she chooses otherwise",
        "status": "completed",
        "guideline_ids": [
          "GL-EULAR-SLE-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic plan protecting her work.",
          "author": "The Human Record generator",
          "created": "2026-11-05T23:00:00-05:00"
        },
        "recorded_date": "2026-04-29"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-EULAR-ACR-CRIT-2019",
        "title": "2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019;71(9):1400-1412",
        "publisher": "EULAR and American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31385462/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-EULAR-SLE-2023",
        "title": "EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 2024;83(1):15-29",
        "publisher": "EULAR",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37827694/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ACR-LN-2024",
        "title": "2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Rheumatol 2025;77(9):1115-1135",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40331662/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-AAO-HCQ-2016",
        "title": "Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016;123(6):1386-1394",
        "publisher": "American Academy of Ophthalmology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/26992838/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-ACR-VAX-2022",
        "title": "2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2023;75(3):333-348",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36597810/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ACR-GIOP-2022",
        "title": "2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 2023;75(12):2088-2102",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37845798/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-ACR-REPRO-2020",
        "title": "2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res 2020;72(4):461-488",
        "publisher": "American College of Rheumatology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32090466/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-FDA-BELIMUMAB-2026",
        "title": "BENLYSTA (belimumab): prescribing information (subcutaneous dosing for lupus nephritis)",
        "publisher": "U.S. National Library of Medicine, DailyMed",
        "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fa3c528-1777-4628-8a55-a69dae2381a3",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-FDA-MMF-2026",
        "title": "CELLCEPT (mycophenolate mofetil): prescribing information (blood count monitoring, embryofetal toxicity, contraception)",
        "publisher": "U.S. National Library of Medicine, DailyMed",
        "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-MC-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, chronic kidney disease and hypertension monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-IDSA-UTI-2010",
        "title": "International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the IDSA and ESCMID. Clin Infect Dis 2011;52(5):e103-e120",
        "publisher": "Infectious Diseases Society of America",
        "url": "https://pubmed.ncbi.nlm.nih.gov/21292654/",
        "version_or_year": "2010"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the EULAR/ACR scoring, the indication for kidney biopsy and the class III result, the choice of mycophenolate with belimumab over a calcineurin inhibitor, the glucocorticoid taper, the contraception choice, and the bone and vaccination plans."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Her lupus, her father's lupus, the ACTH and later steroid treatment, the hip disease and crutches, the 1964 surgery, and her death are documented from a medical society journal article drawing on her letters and the standard biography, PBS, the New Georgia Encyclopedia, a Scribner reference biography, and a medical humanities essay. Avascular necrosis and an early malar rash are physicians' retrospective interpretations (R). Her mother appears only in a documented claim; no relative is quoted or makes any decision."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No behavioral-health diagnosis; mild depressive symptoms at diagnosis are screened and improve; the concealment of her diagnosis within her family is recorded factually without judgment; death recorded without detail."
    }
  }
}
